Molecular Characterization of 9p21 Deletions Shows a Minimal Common Deleted Region Removing CDKN2A Exon 1 and CDKN2B Exon 2 in Diffuse Large B-Cell Lymphomas

被引:8
作者
Guney, Suzan [1 ,2 ]
Bertrand, Philippe [1 ,2 ]
Jardin, Fabrice [1 ,2 ,3 ]
Ruminy, Philippe [1 ,2 ]
Kerckaert, Jean Pierre [4 ]
Tilly, Herve [1 ,2 ,3 ]
Bastard, Christian [1 ,2 ]
机构
[1] Ctr Henri Becquerel, Lab Genet Oncol, F-76038 Rouen, France
[2] IFRMP23, INSERM, U918, Grp Etud Proliferat Lymphoides, Rouen, France
[3] Ctr Henri Becquerel, Dept Hematol, F-76038 Rouen, France
[4] Inst Rech Canc Lille, INSERM, U837, Lille, France
关键词
HYPERMETHYLATION-ASSOCIATED INACTIVATION; T-CELL; HISTOLOGIC TRANSFORMATION; HOMOZYGOUS DELETIONS; V(D)J RECOMBINATION; MTS1 P16(INK4A); POOR-PROGNOSIS; GENES P15; EXPRESSION; FREQUENT;
D O I
10.1002/gcc.20893
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diffuse large B cell lymphoma represent the most frequent subtype of non Hodgkin's lymphoma, accounting for 30-40% of cases. Several studies have shown that CDKN2A and CDKN2B deletions are frequent in these lymphomas. These genes encode the P14ARF, CDKN2A, and CDKN2B proteins which play a key role in the control of the G1/S transition of the cell cycle. Using array CGH and a quantitative multiplex PCR method, we have previously identified such deletions in 36% of cases at diagnosis. Using a walking strategy to approach the breakpoints of these deletions we could identify the breakpoints junction of thirteen deletions in 11 patients and of two unbalanced translocation leading to a loss of these genes. A minimal common deleted region of 22.4 kb containing exon 1 beta of CDKN2A encoding P14ARF and exon 2 of CDKN2B encoding CDKN2B was present in all cases but one. Analysis by quantitative RT PCR showed that the expression level of these genes was decreased in these patients as compared with non deleted cases and that this level was correlated with the deletion status of P14ARF, CDKN2A, and CDKN2B. Analysis of the breakpoint sequences showed that some of them were clustered within a few hundred base-pairs suggesting, even if we failed to identify any clear recombination prone sequences, that in these deletions the rearrangement results from non-random mechanisms. (C) 2011 Wiley-Liss, Inc.
引用
收藏
页码:715 / 725
页数:11
相关论文
共 54 条
  • [1] Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
    Alizadeh, AA
    Eisen, MB
    Davis, RE
    Ma, C
    Lossos, IS
    Rosenwald, A
    Boldrick, JG
    Sabet, H
    Tran, T
    Yu, X
    Powell, JI
    Yang, LM
    Marti, GE
    Moore, T
    Hudson, J
    Lu, LS
    Lewis, DB
    Tibshirani, R
    Sherlock, G
    Chan, WC
    Greiner, TC
    Weisenburger, DD
    Armitage, JO
    Warnke, R
    Levy, R
    Wilson, W
    Grever, MR
    Byrd, JC
    Botstein, D
    Brown, PO
    Staudt, LM
    [J]. NATURE, 2000, 403 (6769) : 503 - 511
  • [2] Batova A, 1997, CANCER RES, V57, P832
  • [3] Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-Hodgkin lymphoma:: Relationship with tumor aggressiveness
    Bertrand, P
    Courel, MN
    Maingonnat, C
    Jardin, F
    Tilly, H
    Bastard, C
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (02) : 207 - 212
  • [4] Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas
    Bertrand, P.
    Bastard, C.
    Maingonnat, C.
    Jardin, F.
    Maisonneuve, C.
    Courel, M-N
    Ruminy, P.
    Picquenot, J-M
    Tilly, H.
    [J]. LEUKEMIA, 2007, 21 (03) : 515 - 523
  • [5] Disruption of the multiple tumor suppressor gene MTS1/p16(INK4a)/CDKN2 by illegitimate V(D)J recombinase activity in T-cell acute lymphoblastic leukemias
    Cayuela, JM
    Gardie, B
    Sigaux, F
    [J]. BLOOD, 1997, 90 (09) : 3720 - 3726
  • [6] Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia
    Cayuela, JM
    Madani, A
    Sanhes, L
    Stern, MH
    Sigaux, F
    [J]. BLOOD, 1996, 87 (06) : 2180 - 2186
  • [7] HOMOZYGOUS MTS1 (P16(INK4A)) DELETION IN PRIMARY TUMOR-CELLS OF 163 LEUKEMIC PATIENTS
    CAYUELA, JM
    HEBERT, J
    SIGAUX, F
    [J]. BLOOD, 1995, 85 (03) : 854 - 854
  • [8] Cuomo CA, 1996, MOL CELL BIOL, V16, P5683
  • [9] Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells
    Drexler, HG
    [J]. LEUKEMIA, 1998, 12 (06) : 845 - 859
  • [10] Dreyling MH, 1998, GENE CHROMOSOME CANC, V22, P72, DOI 10.1002/(SICI)1098-2264(199805)22:1<72::AID-GCC10>3.0.CO